Grown Rogue International (GRUSF) Revenue (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Revenue came in at $9.2 million in Q1 2026, up 28.05% year-on-year from $7.2 million in Q1 2025, and up 100.0% quarter-over-quarter from -$16499.5 billion in Q4 2025.
Grown Rogue International (GRUSF) Revenue (2009 - 2026) Analysis & Trends
Grown Rogue International's Revenue history runs 17 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- On a quarterly basis, Revenue rose 28.05% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was -$5576.4 billion, a 12519692.88% decrease from a year earlier, with the FY2025 full-year figure at $32.4 million, up 21.81% from the prior year.
- Revenue rose to $9.2 million in Q1 2026 per GRUSF's latest filing, from -$16499.5 billion in the prior quarter.
- Across five years, Revenue topped out at $5559.5 billion in Q2 2025 and bottomed at -$16499.5 billion in Q4 2025.
- The 5-year median for Revenue is $6.7 million (2024), against an average of -$371.8 billion.
- Biggest YoY gain for Revenue was 104632296.3% in 2025; the steepest drop was 61976161.19% in 2025.
- Year by year, Revenue stood at $3.7 million in 2022, then retreated by 2.54% to $3.6 million in 2023, then jumped by 631.77% to $26.6 million in 2024, then plunged by 61976161.19% to -$16499.5 billion in 2025, then soared by 100.0% to $9.2 million in 2026.
- Per Business Quant, the three latest GRUSF Revenue figures stand at $9.2 million (Q1 2026), -$16499.5 billion (Q4 2025), and $5363.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Grown Rogue International | 99.32 Mn | 85.61 Mn | 3.96 Mn | 9.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.16 Mn |
| Dec 31, 2025 | -16,499.45 Bn |
| Sep 30, 2025 | 5,363.49 Bn |
| Jun 30, 2025 | 5,559.53 Bn |
| Mar 31, 2025 | 7.15 Mn |
| Dec 31, 2024 | 26.62 Mn |
| Sep 30, 2024 | 5.13 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 6.65 Mn |
| Dec 31, 2023 | 3.64 Mn |
| Oct 31, 2023 | 18.82 Mn |
| Jul 31, 2023 | 12.30 Mn |
| Apr 30, 2023 | 6.00 Mn |
| Jan 31, 2023 | 4.53 Mn |
| Jan 31, 2022 | 3.73 Mn |
| Oct 31, 2021 | 3.76 Mn |
| Jul 31, 2021 | 3.03 Mn |
| Apr 30, 2021 | 1.54 Mn |
| Jan 31, 2021 | 1.05 Mn |
| Oct 31, 2020 | 1.06 Mn |